These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
249 related articles for article (PubMed ID: 35543075)
61. Liquid biopsy in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA. Ye Q; Ling S; Zheng S; Xu X Mol Cancer; 2019 Jul; 18(1):114. PubMed ID: 31269959 [TBL] [Abstract][Full Text] [Related]
62. Circulating tumor cells: advances in detection methods, biological issues, and clinical relevance. Sun YF; Yang XR; Zhou J; Qiu SJ; Fan J; Xu Y J Cancer Res Clin Oncol; 2011 Aug; 137(8):1151-73. PubMed ID: 21681690 [TBL] [Abstract][Full Text] [Related]
63. Longitudinal enumeration and cluster evaluation of circulating tumor cells improve prognostication for patients with newly diagnosed metastatic breast cancer in a prospective observational trial. Larsson AM; Jansson S; Bendahl PO; Levin Tykjaer Jörgensen C; Loman N; Graffman C; Lundgren L; Aaltonen K; Rydén L Breast Cancer Res; 2018 Jun; 20(1):48. PubMed ID: 29884204 [TBL] [Abstract][Full Text] [Related]
64. Clinical significance of glypican-3-positive circulating tumor cells of hepatocellular carcinoma patients: A prospective study. Hamaoka M; Kobayashi T; Tanaka Y; Mashima H; Ohdan H PLoS One; 2019; 14(5):e0217586. PubMed ID: 31141571 [TBL] [Abstract][Full Text] [Related]
66. Circulating tumor cells as biomarkers in head and neck cancer: recent advances and future outlook. Tinhofer I; Staudte S Expert Rev Mol Diagn; 2018 Oct; 18(10):897-906. PubMed ID: 30199647 [TBL] [Abstract][Full Text] [Related]
67. Circulating tumor cells: a multifunctional biomarker. Yap TA; Lorente D; Omlin A; Olmos D; de Bono JS Clin Cancer Res; 2014 May; 20(10):2553-68. PubMed ID: 24831278 [TBL] [Abstract][Full Text] [Related]
68. Enumeration and Characterization of Circulating Tumor Cells in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization. Espejo-Cruz ML; González-Rubio S; Espejo JJ; Zamora-Olaya JM; Alejandre-Altamirano RM; Prieto-Torre M; Linares CI; Guerrero-Misas M; Barrera-Baena P; Poyato-González A; Sánchez-Frías M; Ayllón MD; Rodríguez-Perálvarez ML; de la Mata M; Ferrín G Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768881 [TBL] [Abstract][Full Text] [Related]
69. Genome‑wide copy number analysis of circulating tumor cells in breast cancer patients with liver metastasis. Zou L; Imani S; Maghsoudloo M; Shasaltaneh MD; Gao L; Zhou J; Wen Q; Liu S; Zhang L; Chen G Oncol Rep; 2020 Sep; 44(3):1075-1093. PubMed ID: 32705227 [TBL] [Abstract][Full Text] [Related]
70. Hepatocellular Carcinoma-Circulating Tumor Cells Expressing PD-L1 Are Prognostic and Potentially Associated With Response to Checkpoint Inhibitors. Winograd P; Hou S; Court CM; Lee YT; Chen PJ; Zhu Y; Sadeghi S; Finn RS; Teng PC; Wang JJ; Zhang Z; Liu H; Busuttil RW; Tomlinson JS; Tseng HR; Agopian VG Hepatol Commun; 2020 Oct; 4(10):1527-1540. PubMed ID: 33024921 [TBL] [Abstract][Full Text] [Related]
71. Outcomes of anatomical versus non-anatomical resection for hepatocellular carcinoma according to circulating tumour-cell status. Qi LN; Ma L; Chen YY; Chen ZS; Zhong JH; Gong WF; Lu Y; Xiang BD; Li LQ Ann Med; 2020; 52(1-2):21-31. PubMed ID: 31876201 [No Abstract] [Full Text] [Related]
72. Genomic Landscape of Liquid Biopsy for Hepatocellular Carcinoma Personalized Medicine. Moldogazieva NT; Zavadskiy SP; Terentiev AA Cancer Genomics Proteomics; 2021; 18(3 Suppl):369-383. PubMed ID: 33994362 [TBL] [Abstract][Full Text] [Related]
73. The Presence of Circulating Tumor Cell Cluster Characterizes an Aggressive Hepatocellular Carcinoma Subtype. Yu JJ; Shu C; Yang HY; Huang Z; Li YN; Tao R; Chen YY; Chen Q; Chen XP; Xiao W Front Oncol; 2021; 11():734564. PubMed ID: 34722281 [TBL] [Abstract][Full Text] [Related]
74. Incorporating MicroRNA into Molecular Phenotypes of Circulating Tumor Cells Enhances the Prognostic Accuracy for Patients with Metastatic Breast Cancer. Tan W; Liang G; Xie X; Jiang W; Tan L; Sanders AJ; Liu Z; Ling Y; Zhong W; Tian Z; Lin W; Gong C Oncologist; 2019 Nov; 24(11):e1044-e1054. PubMed ID: 31300482 [TBL] [Abstract][Full Text] [Related]
75. Significance of circulating tumor cells in the portal vein regarding metastases and vascular invasion in hepatocellular carcinoma patients. Zhao X; Zhao J; Tao L; Pan Y; Yang L; Zhang X; Yuan J; Zhu H J Gastrointest Oncol; 2021 Dec; 12(6):3050-3060. PubMed ID: 35070429 [TBL] [Abstract][Full Text] [Related]
76. Molecular detection of epithelial-mesenchymal transition markers in circulating tumor cells from pancreatic cancer patients: Potential role in clinical practice. Zhao XH; Wang ZR; Chen CL; Di L; Bi ZF; Li ZH; Liu YM World J Gastroenterol; 2019 Jan; 25(1):138-150. PubMed ID: 30643364 [TBL] [Abstract][Full Text] [Related]
77. Fibronectin Regulation of Integrin B1 and SLUG in Circulating Tumor Cells. Huaman J; Naidoo M; Zang X; Ogunwobi OO Cells; 2019 Jun; 8(6):. PubMed ID: 31226820 [TBL] [Abstract][Full Text] [Related]
78. Circulating Tumor Cells and Implications of the Epithelial-to-Mesenchymal Transition. Lowes LE; Allan AL Adv Clin Chem; 2018; 83():121-181. PubMed ID: 29304900 [TBL] [Abstract][Full Text] [Related]
79. Effect of surgical margin on recurrence based on preoperative circulating tumor cell status in hepatocellular carcinoma. Zhou KQ; Sun YF; Cheng JW; Du M; Ji Y; Wang PX; Hu B; Guo W; Gao Y; Yin Y; Huang JF; Zhou J; Fan J; Yang XR EBioMedicine; 2020 Dec; 62():103107. PubMed ID: 33181461 [TBL] [Abstract][Full Text] [Related]
80. Prospective assessment of the prognostic value of circulating tumor cells and their clusters in patients with advanced-stage breast cancer. Mu Z; Wang C; Ye Z; Austin L; Civan J; Hyslop T; Palazzo JP; Jaslow R; Li B; Myers RE; Jiang J; Xing J; Yang H; Cristofanilli M Breast Cancer Res Treat; 2015 Dec; 154(3):563-71. PubMed ID: 26573830 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]